Sep 07, 2023 / 01:30PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Insulet. With us, we have: Jim Hollingshead, the CEO; Wayde McMillan, the CFO; and Trang Ly, Senior Vice President and Medical Director; also in the audience, Deb Gordon, Investor Relations.
So in terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand, we'll come around with a mic. Jim, Wayde and Trang, thanks so much for being here.
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Great to be here, Larry. Thank you.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystSo let's start with the GLP-1s. The updates on GLP-1s are more and more positive each day, it seems. So Jim, can
Trustpilot
